Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Behrends CN, Eggman AA, Gutkind S, Bresnahan MP, Fluegge K, Laraque F, Litwin AH, Meissner P, Shukla SJ, Perumalswami PV, Weiss J, Wyatt BE, Schackman BR. A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. J Public Health Manag Pract. 2019 May/Jun;25(3):253-261. doi: 10.1097/PHH.0000000000000806. PubMed PMID: 29975342; PubMed Central PMCID: PMC6314903.
Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR. Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e76-e78. doi: 10.1097/QAI.0000000000001792. PubMed PMID: 29985266; PubMed Central PMCID: PMC6347107.
Schackman BR, Gutkind S, Morgan JR, Leff JA, Behrends CN, Delucchi KL, McKnight C, Perlman DC, Masson CL, Linas BP. Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend. 2018 Apr 1;185:411-420. doi: 10.1016/j.drugalcdep.2017.11.031. Epub 2018 Feb 21. PubMed PMID: 29477574; PubMed Central PMCID: PMC5889754.
Behrends CN, Li CS, Gibson DR. Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities. Subst Use Misuse. 2017 Jul 29;52(9):1151-1159. doi: 10.1080/10826084.2017.1299182. Epub 2017 May 30. PubMed PMID: 28557553; PubMed Central PMCID: PMC5592728.
Lucas KD, Eckert V, Behrends CN, Wheeler C, MacGowan RJ, Mohle-Boetani JC. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012. MMWR Morb Mortal Wkly Rep. 2016 Feb 26;65(7):178-81. doi: 10.15585/mmwr.mm6507a3. PubMed PMID: 26914322.
What would you like to do?
  • Page of 1